PEROSIA NANCY J
D/No: 58/E1 Shambha sureksha Havelock road, Ooty The Nilgiris – 643001
OBJECTIVE
My goal is to become associated with a company where I can utilize my skills and gain further experience while enhancing the company’s productivity and reputation.
EXPERIENCE
PROJECT
COTIVITI INDIA PRIVATE LIMITED – COIMBATORE – 641035
CRC MEDICAL CODER
I have nearly 2 years of experience at Cotiviti as a Certified Risk Adjustment Coder, bringing 2 year of experience, with a focus on projects involving Elevance CRA, MRA, and Aetna MRA.
4/7/2023 – 6/6/2025
EDUCATION
KARPAGAM ACADEMY OF HIGHER EDUCATION (DEEMED TO BE UNIVERSITY)
M.Sc BIOTECHNOLOGY
9.31 CGPA
2023
KARPAGAM ACADEMY OF HIGHER EDUCATION (DEEMED TO BE UNIVERSITY)
B.Sc Biotechnology
8.94 CGPA
2021
SRI SHANTHI VIJAI GIRLS HIGHER SECONDARY SCHOOL
HSC
73%
2018
BETHLEHEM GIRLS HIGHER SECONDARY SCHOOL
SSLC
82%
2016
CERTIFICATIONS COURSES
Computational Methods in Drug Discovery: The Role of Computer-Aided Drug Design (CADD) in Modern Pharmaceutical Development for Cardiovascular Disease 2025- ongoing
Computer-Aided Drug Design (CADD) is a crucial tool in pharmaceutical research, facilitating the identification and development of therapies for complicated disorders, including cardiovascular disease (CVD). The current study reveals the uses of molecular docking techniques like phytochemical inhibitors targeting the Apco3 enzyme, here we taken the enzyme 6Y43 A-chain structure was identified as a potential CVD-related target. We tested a total of 180 phytochemical compounds using in silico docking methods. This study highlights how phytochemicals, which come from natural sources, can be used in conjunction with computational techniques to help create safer and more effective treatments for cardiovascular diseases. The study’s findings demonstrate the critical role that computational approaches play in modern drug discovery pipelines, offering a strong basis for further experimental validation and potentially advancing clinical applications.
STUDY ON MECENCHYMAL STEM CELLS AND COVID-19 (UG PROJECT)2021
COVID-19 has been rapidly extended through out the world via human-to-human contact. hCoV-19 affects the respiratory tract causes severe pneumonia and other acute respiratory disorders. No antiviral drug is available to treat COVID-19 at present. Aggressive inflammation is believed to cause severe lung damage followed by COVID-19. The immunomodulatory and regenerative properties of mesenchymal stem cells made clinicians to investigate their efficacy against COVID-19 patients suffered from pneumonia. Clinical studies have reported the efficiency of MSCs in COVID-19 management. However, precautions must be taken as MSCs may suppress innate immunoprotective T cells activation. In this review, we discuss the outcomes of the stem cell therapy. COVID-19 patients, nonspecific immunomodulation of MSCs against virus and the possibility of alternative treatment with chimeric antigen receptor engineered hematopoietic stem cells, soluble recombinant human ACE2, and cell-free secreted factors againstCOVID-19.
GC- MS PROFILING OF PHYTOCOMPOUNDS FROM VARIOUS PARTS OF DELONIX ELATA ( L.) GAMBLE: A COMPARATIVE STUDY- 2023
The identification of volatile organic organic compounds from various parts of Delonix elata for extract.A compatitive study from methanolic fractions of leaf, flower and bark extracts in terms of qualitative and quantitative composition was done on Gas chromatography – mass spectrometry ( GC – MS ).The compounds were identified belongs to different classes of organic compounds i.e esters, fatty acids, phenols, sugars, amino acids and hydrocarbons .Most of compounds were present in flowers while some compounds are unique.Hence we determined the total flavonoid content of flower extracts. flavonoids are the dominated compounds when compared to phenolics. Further we determined Nitric oxide radical scavenging assay and superoxide radical scavenging assay activity for all extracts.The flower extract as highest antioxidant activity.Based on those findings ,we suggested D.elata are the potential sources in field of medicines and pharmaceutical sciences which need further investigation.
AI ML in Biology, Bioinformatics & Computational Biology. (Biotechnika)- 2025
AI ML in healthcare in medical coding and billing – AAPC -2025
AI Mastery Worshop- Outskill- 2025
ADVANCE PROGRAM IN PHARMACOVIGILANCE (Biotechnika) -2025
CRISPAR CAS TECHNOLOGY (Value added course) – 2022
Experimental Biotechnology ( NPTEL) – 2020
Forest Biometry (NPTEL) – 2019
Reference
Dr.A.SANGILIMUTHU
Karpagam Academy of Higher Education
Professor and Head, Department of Biotechnology
[Email Hidden] | [Phone Hidden]
Interests
Bioinformatics, Animal biotechnology, Drug discovery, AI in healthcare
Achievements & Awards
SCHOLARSHIP : Post graduation meritorious scholarship from KARPAGAM ACADEMY OF HIGHER EDUCATION for M.Sc programme.
INTERNSHIP
DECLARATION
PLACE
Signature:
Perosia Nancy J
“`
Cover Letter:
Perosia Nancy.J
Coimbatore
**Hiring Manager**
Serotonin Labs
Dear Hiring Manager,
I am writing to express my interest in the position at Serotonin Labs, With over two years of experience in research environments and a strong foundation in computational biology, I bring a unique blend of scientific expertise and analytical thinking to this opportunity. While my familiarity with Angular and NodeJS is at a basic level, I am quick to learn, and I’m currently enhancing my proficiency to better align with the full-stack needs of the role.
My background in biotechnology and computational analysis, including hands-on experience with Python, R, and bioinformatics tools, has equipped me with a problem-solving mindset and technical agility. I’ve contributed to multiple data-driven projects, and my role as a Certified Risk Adjustment Coder has deepened my attention to detail and precision—skills I know are just as valuable in software development workflows.
I’m excited about Serotonin Labs’ mission to blend innovation with wellness, and I’m eager to apply my cross-disciplinary strengths to support that vision. I would appreciate the chance to grow further within your dynamic team while contributing to impactful solutions.
Thank you for considering my application. I’d welcome the opportunity to discuss how my background might complement your needs.
Warm regards,
**Perosia Nancy J**
Leave a Reply